STEPHANIE HENDRICK: Open Payments
NPI 1790241594 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 67 payments from 24 companies in 2025. Trend: 2023 $2,091 · 2024 $1,635 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $305 |
| PFIZER INC. | 6 | $135 |
| Novo Nordisk Inc | 6 | $110 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Endo USA, Inc. | 3 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
Products named: UBRELVY, NURTEC ODT, TRELEGY ELLIPTA, Wegovy, QULIPTA, AVEED, GEMTESA, VRAYLAR.
Industry payments across VA — which companies pay providers there.
